State TN
Clinical Trials in Tennessee
Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.
Top Conditions in Tennessee
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrom...
Condition
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06654895 N/A
Recruiting
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
Condition
Sepsis, Septic Shock
Enrollment
700 pts
Location
United States
Sponsor
Bluejay Diagnostics, Inc.
NCT02328677 N/A
Recruiting
ColoCare Study - Colorectal Cancer Cohort
Condition
Colorectal Cancer
Enrollment
5,000 pts
Location
United States, Germany
Sponsor
University of Utah
NCT06914128 Phase 1, Phase 2
Recruiting
A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Part...
Condition
MTAP-deleted Solid Tumors
Enrollment
370 pts
Location
United States, Australia, Belgium
Sponsor
Bayer
NCT06082037 Phase 3
Recruiting
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Partici...
Condition
Lung Transplant Rejection
Enrollment
180 pts
Location
United States, Australia, Austria
Sponsor
Sanofi
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06057675 Phase 2
Recruiting
Tranexamic Acid in Nasal Mohs Reconstruction
Condition
Postoperative Bleeding
Enrollment
100 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
NCT05758545 N/A
Recruiting
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device...
Condition
Diabetic Foot Ulcer
Enrollment
450 pts
Location
United States
Sponsor
Piomic Medical
NCT06068075 N/A
Recruiting
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Dia...
Condition
Ewing Sarcoma
Enrollment
340 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT04831164 N/A
Recruiting
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study
Condition
Rotator Cuff Tears
Enrollment
3,500 pts
Location
United States
Sponsor
University of Michigan
NCT03686709 N/A
Recruiting
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
Condition
Hepatocellular Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
University of Tennessee
NCT07229430 N/A
Recruiting
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Dev...
Condition
Skin Laxity (Submental and Neck)
Enrollment
273 pts
Location
United States
Sponsor
CLASSYS Inc.
NCT04524871 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treat...
Condition
Advanced Liver Cancers
Enrollment
518 pts
Location
United States, China, France
Sponsor
Hoffmann-La Roche
NCT07465432 Phase 4
Recruiting
Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
Condition
Drug Clearance After Severe Burn Injury
Enrollment
12 pts
Location
United States
Sponsor
University of Tennessee
NCT02679144 Phase 2
Recruiting
Neuroblastoma Maintenance Therapy Trial
Condition
Neuroblastoma
Enrollment
441 pts
Location
United States, Canada
Sponsor
Giselle Sholler
NCT06765109 Phase 3
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Condition
Non-small Cell Lung Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Nuvalent Inc.
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
NCT07221149 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Enrollment
690 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05421208 N/A
Recruiting
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndr...
Condition
Post-acute COVID-19 Syndrome
Enrollment
60 pts
Location
United States
Sponsor
Vanderbilt University Medical
NCT06043817 Phase 1, Phase 2
Recruiting
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or...
Condition
Non-Small Cell Lung Cancer
Enrollment
251 pts
Location
United States, France, Germany
Sponsor
Pierre Fabre Medicament
NCT03050268 N/A
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Condition
Acute Leukemia
Enrollment
1,500 pts
Location
United States
Sponsor
St. Jude Children's Research H